Michael O'Grady
Chairman and CEO at Northern Trust Corporation
Sits on 2 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Northern Trust Corporation, 3 years.
Chief executive roles
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Apr 24, 2026 | Abbott Laboratories | Grant or award | +2,286 | โ | โ |
| Mar 1, 2026 | Northern Trust Corporation | Shares withheld for tax | โ11,129 | $143.15 | $1,593,116 |
| Feb 17, 2026 | Northern Trust Corporation | Grant or award | +72,642 | โ | โ |
| Feb 17, 2026 | Northern Trust Corporation | Shares withheld for tax | โ32,181 | $147.24 | $4,738,330 |
| Feb 5, 2026 | Northern Trust Corporation | Grant or award | +19,437 | โ | โ |
| Jan 29, 2026 | Northern Trust Corporation | Option exercise | +34,489 | $58.25 | $2,008,984 |
| Jan 29, 2026 | Northern Trust Corporation | Shares withheld for tax | โ21,739 | $150.78 | $3,277,806 |
| Dec 3, 2025 | Northern Trust Corporation | Shares withheld for tax | โ770 | $131.32 | $101,116 |
| Apr 25, 2025 | Abbott Laboratories | Grant or award | +1,635 | โ | โ |
| Mar 1, 2025 | Northern Trust Corporation | Shares withheld for tax | โ11,684 | $110.27 | $1,288,395 |
| Feb 18, 2025 | Northern Trust Corporation | Grant or award | +63,107 | โ | โ |
| Feb 18, 2025 | Northern Trust Corporation | Shares withheld for tax | โ27,957 | $112.69 | $3,150,474 |
| Feb 5, 2025 | Northern Trust Corporation | Grant or award | +19,012 | โ | โ |
| Jan 30, 2025 | Northern Trust Corporation | Option exercise | +23,739 | $70.21 | $1,666,715 |
| Jan 30, 2025 | Northern Trust Corporation | Shares withheld for tax | โ17,432 | $113.21 | $1,973,477 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.